# CSPC Pharmaceutical Group Limited (CHJTF)

> Source: Nexqual · https://nexqual.com/CHJTF · data as of 2026-10-21 20:00 UTC · cite as "Nexqual, CSPC Pharmaceutical Group Limited (CHJTF), nexqual.com/CHJTF" · informational, not investment advice.

**Price:** USD 1.26 (+13.51% on the day) · last close of Oct 21, 2026; US market closed, not a live price. Prev close 1.11 · day 1.26–1.26 · 52w 0.94–1.39 · market cap $14.4B · PNK

## Key facts
- Analysts: None.
- Total return with dividends: 1Y +17.9% vs S&P 500 +14.4%; 5Y +22.6% vs S&P 500 +77.0%.
- Next earnings: 2026-11-19, EPS estimate USD —, revenue estimate $7.66B.

## Analysts
Consensus None.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +17.9% | +22.6% |
| S&P 500 (SPY) | +14.4% | +77.0% |
| Per year | +18.0% | +4.2% |
| Volatility (annualized) | 36.4% | 48.1% |
| Max drawdown | -29.5% (Feb 2026→Jun 2026) | -54.2% (Jan 2022→Sep 2024) |

## Peers (Drug Manufacturers - General)
BIIB (Biogen Inc.) USD 250.37 -1.37% · GRFS (Grifols, S.A.) USD 7.54 +1.14% · OGN (Organon & Co.) USD 13.76 +0.04% · SNY (Sanofi) USD 41.5 -1.11% · GSK (GSK plc) USD 50.63 -1.14% · BMY (Bristol-Myers Squibb Company) USD 61.55 -2.31%

## More
Full page: https://nexqual.com/CHJTF · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | — | — | — | $7.66B | — |
| Next quarter (ends 2026-12-31) | — | — | — | $7.56B | — |
| Current fiscal year (ends 2026-12-31) | — | — | — | $38.49B | — |
| Next fiscal year (ends 2027-12-31) | — | — | — | $35.70B | — |